CYP3A43
Cytochrome P450, family 3, subfamily A, polypeptide 43 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||||
Symbols | CYP3A43 ; MGC119315; MGC119316 | ||||||||||
External IDs | Template:OMIM5 Template:MGI HomoloGene: 75118 | ||||||||||
| |||||||||||
RNA expression pattern | |||||||||||
More reference expression data | |||||||||||
Orthologs | |||||||||||
Template:GNF Ortholog box | |||||||||||
Species | Human | Mouse | |||||||||
Entrez | n/a | n/a | |||||||||
Ensembl | n/a | n/a | |||||||||
UniProt | n/a | n/a | |||||||||
RefSeq (mRNA) | n/a | n/a | |||||||||
RefSeq (protein) | n/a | n/a | |||||||||
Location (UCSC) | n/a | n/a | |||||||||
PubMed search | n/a | n/a |
WikiDoc Resources for CYP3A43 |
Articles |
---|
Most recent articles on CYP3A43 |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on CYP3A43 at Clinical Trials.gov Clinical Trials on CYP3A43 at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on CYP3A43
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating CYP3A43 Risk calculators and risk factors for CYP3A43
|
Healthcare Provider Resources |
Causes & Risk Factors for CYP3A43 |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Cytochrome P450, family 3, subfamily A, polypeptide 43, also known as CYP3A43, is a human gene.[1]
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This enzyme has a low level of testosterone hydroxylase activity. Although it bears homology to some drug-metabolizing cytochrome P450s, it is unknown whether the enzyme is also involved in xenobiotic metabolism. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Alternate splicing of this gene results in three transcript variants encoding different isoforms.[1]
References
Further reading
- Smith G, Stubbins MJ, Harries LW, Wolf CR (1999). "Molecular genetics of the human cytochrome P450 monooxygenase superfamily". Xenobiotica. 28 (12): 1129–65. PMID 9890157.
- Finta C, Zaphiropoulos PG (2001). "The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons". Gene. 260 (1–2): 13–23. PMID 11137287.
- Domanski TL, Finta C, Halpert JR, Zaphiropoulos PG (2001). "cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450". Mol. Pharmacol. 59 (2): 386–92. PMID 11160876.
- Westlind A, Malmebo S, Johansson I; et al. (2001). "Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43". Biochem. Biophys. Res. Commun. 281 (5): 1349–55. doi:10.1006/bbrc.2001.4505. PMID 11243885.
- Gellner K, Eiselt R, Hustert E; et al. (2001). "Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene". Pharmacogenetics. 11 (2): 111–21. PMID 11266076.
- Finta C, Zaphiropoulos PG (2002). "Intergenic mRNA molecules resulting from trans-splicing". J. Biol. Chem. 277 (8): 5882–90. doi:10.1074/jbc.M109175200. PMID 11726664.
- Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
- Hillier LW, Fulton RS, Fulton LA; et al. (2003). "The DNA sequence of human chromosome 7". Nature. 424 (6945): 157–64. doi:10.1038/nature01782. PMID 12853948.
- Cauffiez C, Lo-Guidice JM, Chevalier D; et al. (2004). "First report of a genetic polymorphism of the cytochrome P450 3A43 (CYP3A43) gene: identification of a loss-of-function variant". Hum. Mutat. 23 (1): 101. doi:10.1002/humu.9211. PMID 14695544.
- Hillman RT, Green RE, Brenner SE (2005). "An unappreciated role for RNA surveillance". Genome Biol. 5 (2): R8. doi:10.1186/gb-2004-5-2-r8. PMID 14759258.
- Stone A, Ratnasinghe LD, Emerson GL; et al. (2005). "CYP3A43 Pro(340)Ala polymorphism and prostate cancer risk in African Americans and Caucasians". Cancer Epidemiol. Biomarkers Prev. 14 (5): 1257–61. doi:10.1158/1055-9965.EPI-04-0534. PMID 15894682.
- Thompson EE, Kuttab-Boulos H, Yang L; et al. (2006). "Sequence diversity and haplotype structure at the human CYP3A cluster". Pharmacogenomics J. 6 (2): 105–14. doi:10.1038/sj.tpj.6500347. PMID 16314882.
- Shchepotina EG, Nikishina MV, Vavilin VA, Lyakhovich VV (2006). "Analysis of restriction fragment length polymorphism of cytochrome P450 3A43 gene and evaluation of the incidence of CYP3A43*1B allele in europeoid residents of West Siberia". Bull. Exp. Biol. Med. 140 (6): 726–8. PMID 16848237.